Tech giant Intel invests in digital health firm BioFourmis’ $320M Series D


A storied computer processing giant is investing in a local digital health startup, BioFourmis, injecting it with $20 million just four months after it announced a $300 million Series D.

Previous Verona Pharma sees stock jump as COPD drug returns positive results
Next Immunology startup GentiBio signs $1.9B deal with Bristol Myers